BLOODSTREAM INFECTION
Clinical trials for BLOODSTREAM INFECTION explained in plain language.
Never miss a new study
Get alerted when new BLOODSTREAM INFECTION trials appear
Sign up with your email to follow new studies for BLOODSTREAM INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough infections: experimental antibiotic combo tested
Disease control Recruiting nowThis study tests a new IV antibiotic (aztreonam-avibactam) in hospitalized children aged 9 months to 18 years with serious gram-negative bacterial infections. About 48 participants will receive either the new drug or the best available standard treatment. The goal is to see how t…
Matched conditions: BLOODSTREAM INFECTION
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New bandage could slash infection risk for kids in ICU
Prevention Recruiting nowThis study tests whether a special antimicrobial dressing can reduce bloodstream infections from central venous catheters in children in intensive care. About 250 children will be randomly assigned to receive either the antimicrobial dressing or a standard one. The main goal is t…
Matched conditions: BLOODSTREAM INFECTION
Phase: NA • Sponsor: University of Seville • Aim: Prevention
Last updated Jun 26, 2026 18:24 UTC
-
Can a rapid test help doctors pick the right antibiotic faster?
Knowledge-focused Recruiting nowThis study tests whether a rapid lab test can help doctors choose the right antibiotic sooner for patients with bloodstream infections. About 400 adults with positive blood cultures will be randomly assigned to either the rapid test or standard testing. The goal is to see if the …
Matched conditions: BLOODSTREAM INFECTION
Phase: NA • Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Which works better: one antibiotic or two for this superbug?
Knowledge-focused Recruiting nowThis study looks at 790 adults with S. maltophilia infections, a hard-to-treat bacteria. Researchers will compare patients who got one antibiotic versus those who got a combination, to see which group has fewer deaths within 30 days. The goal is to find the best treatment approac…
Matched conditions: BLOODSTREAM INFECTION
Sponsor: Instituto de Investigación Sanitaria Gregorio Marañón • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New antibiotic under the microscope: can it beat superbug infections?
Knowledge-focused Recruiting nowThis study is observing 200 hospitalized adults with carbapenem-resistant Acinetobacter baumannii (CRAB) infections—a type of superbug—who are treated with the antibiotic sulbactam-durlobactam. Researchers will compare their outcomes to patients receiving other treatments to see …
Matched conditions: BLOODSTREAM INFECTION
Sponsor: Sichuan Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Could shorter antibiotic courses be safer for blood cancer patients?
Knowledge-focused Recruiting nowThis study looks at whether blood cancer patients with a serious infection can safely stop antibiotics sooner if they are stable for 72 hours, instead of the usual 10-day course. About 172 adults will be randomly assigned to either a personalized short course or standard long cou…
Matched conditions: BLOODSTREAM INFECTION
Phase: NA • Sponsor: Humanitas University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC